Dandelion Health key facts
as of Oct 2026- Provider of a real-world patient data and clinical AI platform designed to accelerate healthcare AI development and commercialization.
- Dandelion Health is valued at approximately $62.0M as of Oct 2026, set at its seed round, Feb 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $15.9M across 1 recorded rounds; the latest was Early Stage VC ($15.9M) in Feb 2024.
- Notable investors include Primary Venture Partners, Floating Point, Phoenix Venture Partners, Convergent Ventures (San Francisco), Healthier Capital — 7 tracked in total.
- Dandelion Health has filed 1 Form D with the SEC, most recently Mar 2024 ($15.9M sold to 23 investors).
- Status: Privately Held (backing).
Valued at $62.0M at its seed round, Feb 2024. Nothing has traded since.
- ·Watch Dandelion Health: the Monday email on marks, rounds and moves
Dandelion Health funding rounds
1 roundsDandelion Health leadership
- Elliott GreenChief Executive Officer & Founder
- Kiko WemmerGeneral Manager & Vice President
- Nicholas GossenHead
- Ziad ObermeyerChief Scientific Officer & Founder
Dandelion Health valuation
Dandelion Health was valued at $62 million at its seed round in Feb 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Dandelion Health raised?
Dandelion Health has raised $15.9 million across 1 recorded round since 2024. The largest was a $15.9 million early-stage round in Feb 2024.
Dandelion Health has filed 1 Form D with the SEC, most recently in Mar 2024 ($15.9 million sold to 23 investors).
Dandelion Health investors
7 investors are on record for Dandelion Health, including Primary Venture Partners, Floating Point, Phoenix Venture Partners and Convergent Ventures (San Francisco). The early-stage round in Feb 2024 drew 23 investors.
Who runs Dandelion Health
6 people are listed on the Dandelion Health team: 4 executives, 1 board member and 1 advisor or observer, including Elliott Green (Chief Executive Officer) and Ziad Obermeyer (Chief Scientific Officer). 5 of them have a verified direct contact on file.
About Dandelion Health
Provider of a real-world patient data and clinical AI platform designed to accelerate healthcare AI development and commercialization. The company integrates de-identified multimodal clinical data from millions of patient records into regulatory-grade, research-ready datasets, enabling life sciences companies and AI developers to design and validate AI models and generate real-world evidence to bring safer, more effective AI-enabled therapies and tools to market faster.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 20
- Website
- dandelionhealth.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.